We are live on ! Find out more

LFS

Link Fund Solutions Portfolio holdings

AUM $157M

This Fund

S&P 500

This Quarter Est. Return

+29.75%

1 Year Est. Return

–

3 Year Est. Return

–

5 Year Est. Return

–

10 Year Est. Return

–

AUM

$194M

AUM Growth

–

Cap. Flow

+$153M

Cap. Flow % of AUM

79.14%

Top 10 Holdings % Top 10 Hldgs %

100%

Holding

New

Increased

–

Reduced

–

Closed

–

Top Buys

Rank	Stock	Value
1	Theravance Biopharma TBPH	+$102M
2	EVFM Evofem Biosciences, Inc. Common Stock EVFM	+$51.4M

Top Sells

No sells this quarter

Sector Composition

Rank	Sector	Weight
1	Healthcare	100%

Communication Services

Advertising Agencies

Broadcasting

Electronic Gaming & Multimedia

Entertainment

Internet Content & Information

Publishing

Telecom Services

Consumer Discretionary

Apparel Manufacturing

Apparel Retail

Auto Manufacturers

Auto Parts

Auto & Truck Dealerships

Department Stores

Footwear & Accessories

Furnishings, Fixtures & Appliances

Gambling

Home Improvement Retail

Internet Retail

Leisure

Lodging

Luxury Goods

Packaging & Containers

Personal Services

Recreational Vehicles

Residential Construction

Resorts & Casinos

Restaurants

Specialty Retail

Textile Manufacturing

Travel Services

Consumer Staples

Beverages - Brewers

Beverages - Non-Alcoholic

Beverages - Wineries & Distilleries

Confectioners

Discount Stores

Education & Training Services

Farm Products

Food Distribution

Grocery Stores

Household & Personal Products

Packaged Foods

Tobacco

Energy

Oil & Gas Drilling

Oil & Gas Equipment & Services

Oil & Gas Exploration & Production

Oil & Gas Integrated

Oil & Gas Midstream

Oil & Gas Refining & Marketing

Thermal Coal

Uranium

Financials

Asset Management

Banks - Diversified

Banks - Regional

Capital Markets

Credit Services

Diversified Insurance

Financial Conglomerates

Financial Data & Stock Exchanges

Insurance Brokers

Life Insurance

Mortgage Finance

Property & Casualty Insurance

Reinsurance

Shell Companies

Specialty - Insurance

Healthcare

Biotechnology

Diagnostics & Research

Drug Manufacturers - General

Drug Manufacturers - Specialty & Generic

Healthcare Plans

Health Information Services

Medical Care Facilities

Medical Devices

Medical Distribution

Medical Instruments & Supplies

Pharmaceutical Retailers

Industrials

Aerospace & Defense

Airlines

Airports & Air Services

Building Products & Equipment

Business Equipment & Supplies

Conglomerates

Consulting Services

Electrical Equipment & Parts

Engineering & Construction

Farm & Heavy Construction Machinery

Industrial Distribution

Infrastructure Operations

Integrated Freight & Logistics

Marine Shipping

Metal Fabrication

Pollution & Treatment Controls

Railroads

Rental & Leasing Services

Security & Protection Services

Specialty Business Services

Specialty Industrial Machinery

Staffing & Employment Services

Tools & Accessories

Trucking

Waste Management

Materials

Agricultural Inputs

Aluminum

Building Materials

Chemicals

Coking Coal

Copper

Gold

Lumber & Wood Production

Other Industrial Metals & Mining

Other Precious Metals & Mining

Paper & Paper Products

Silver

Specialty Chemicals

Steel

Real Estate

Diversified REIT

Healthcare Facilities REIT

Hotel & Motel REIT

Industrial REIT

Mortgage REIT

Office REIT

Real Estate Development

Real Estate Diversified

Real Estate Services

Residential REIT

Retail REIT

Specialty REIT

Technology

Communication Equipment

Computer Hardware

Consumer Electronics

Electronic Components

Electronics & Computer Distribution

Information Technology Services

Scientific & Technical Instruments

Semiconductor Equipment & Materials

Semiconductors

Software - Application

Software - Infrastructure

Solar

Utilities

Diversified Utilities

Electric Utilities

Gas Utilities

Independent Power Producers

Renewable Electricity

Water Utilities

#	Name	Market Value	Portfolio Weight	Shares or Principal	Change in Stake	Capital Flow
1	1 Theravance Biopharma TBPH $871M	$135M	69.86%	+5,251,349	New	+$102M
2	EVFM 2 DELISTED Evofem Biosciences, Inc. Common Stock EVFM	$58.4M	30.14%	+609,234	New	+$51.4M

Similar funds

BIA

BMT Investment Advisors Berwyn, Pennsylvania $159M AUM 12.04% 1-Year Est. Return

CGM

Centenus Global Management New York $153M AUM 20.46% 1-Year Est. Return

GCM

Grisanti Capital Management New York $163M AUM 5.09% 1-Year Est. Return

VDFA

Vickerman & Driscoll Financial Advisors Spokane, Washington $163M AUM 7.99% 1-Year Est. Return

FCM

Ferox Capital Management London, United Kingdom $164M AUM 0.42% 1-Year Est. Return

SCM

Schneider Capital Management Berwyn, Pennsylvania $175M AUM 42.51% 1-Year Est. Return

JAM

Jolley Asset Management Rocky Mount, North Carolina $130M AUM 10.62% 1-Year Est. Return

AIS

Accurate Investment Solutions Seven Fields, Pennsylvania $123M AUM 9.07% 1-Year Est. Return

Link Fund Solutions's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Link Fund Solutions, which disclosed 2 positions worth $194M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Theravance Biopharma: 5,251,349 shares worth $135M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

Link Fund Solutions's largest Q4 2019 buy was Theravance Biopharma: 5,251,349 shares worth $135M.
Link Fund Solutions's ten largest holdings make up 100% of its $194M portfolio in Q4 2019.
Link Fund Solutions disclosed 2 positions in Q4 2019, its first 13F filing on record.

Based on Link Fund Solutions's 13F filing for Q4 2019, filed 28 Jan 2020.